| Literature DB >> 28210089 |
Serhat Bor1, Gul Kitapcioglu1, Elmas Kasap1.
Abstract
AIM: To evaluate the prevalence of gastroesophageal reflux disease (GERD) with additional symptoms, relationship with Helicobacter pylori (H. pylori) of this country-wide study.Entities:
Keywords: Epidemiology; Gastroesophageal reflux disease; Heartburn; Prevalence; Regurgitation
Mesh:
Substances:
Year: 2017 PMID: 28210089 PMCID: PMC5291858 DOI: 10.3748/wjg.v23.i3.525
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Figure 1Prevalence of gastroesophageal reflux disease according to education.
Figure 2Prevalence of gastroesophageal reflux disease symptoms. GERD: Gastroesophageal reflux disease.
Figure 3Prevalence of gastroesophageal reflux disease and Helicobacter pylori positivity (between parenthesis) according to geographicraphical areas.
Consumption of medications
| Antacids/alginate | 31.2% | 26.9% | 9.2% |
| Acid inhibitors | 28.2% | 21.5% | 7.2% |
| Aspirin | 40.0% | 40.9% | 45.1% |
| NSAIDs | 29.0% | 30.1% | 22.2% |
NSAID: Non-steroidal anti-inflammatory drug.
Body mass index and gastroesophageal reflux disease prevalence
| BMI (kg/m2) | ||
| ≤ 18.5 | 107 | 16 (15.0) |
| 18.6 - 24.9 | 1272 | 254 (20.0) |
| 25.0 - 29.9 | 1110 | 257 (23.2) |
| 30+ | 492 | 140 (28.5) |
| Mantel-Haenszel | ||
BMI: Body mass index; GERD: Gastroesophageal reflux disease.
Prevalence of additional symptoms according to symptom frequency
| NCCP (179) | 35.9% | 30.2% | 13.7% |
| Dysphagia (230) | 24.5% | 18.6% | 4.6% |
| Belching (221) | 36.8% | 28.3% | 11.9% |
| Nausea (601) | 29.7% | 10.6% | 3.4% |
| Vomiting (417) | 15.7% | 3.4% | 0.9% |
| Hematemesis (33) | 2.6% | 1.4% | 0.2% |
| Hiccup (68) | 6.4% | 7.0% | 1.2% |
| Cough (70) | 16.3% | 11.7% | 5.9% |
| Asthma (24) | 8.2% | 3.8% | 3.7% |
| Hoarseness (48) | 6.2% | 4.0% | 1.3% |
| Chronic pharyngitis (32) | 8.4% | 7.2% | 3.3% |
P < 0.05 vs subjects without symptoms;
P < 0.05 vs subjects with occasional symptoms. NCCP: Noncardiac chest pain.
Prevalence of additional symptoms in studies using the Mayo questionnaire
| NCCP | 23.1 | 35.9 | 15.5 | 37.6 | 34.7 |
| Dysphagia | 13.5 | 24.5 | 25.5 | 26.8 | 6.5 |
| Odynophagia | - | - | 34.4 | - | 10.7 |
| Globus | 7.0 | 23.8 | 25.5 | 26.3 | 15.2 |
| Dyspepsia | 10.6 | 60.2 | 38.7 | 29.3 | |
| Belching | - | 36.8 | 43.0 | - | - |
| Nausea | - | 29.7 | 53.8 | - | - |
| Vomiting | - | 15.7 | 29.1 | - | - |
| Hiccup | - | 6.4 | 6.8 | - | - |
| Cough | - | 16.3 | 36.7 | - | 8.9 |
| Asthma | 9.3 | 8.2 | - | 6.7 | 4.2 |
| Pharyngeal symptoms and Hoarseness | 14.3 | 7.3 | 10.4 | 21.8 | 9.4 |
NCCP: Noncardiac chest pain.